Clinical outcomes after Viremia among people receiving dolutegravir vs efavirenz-based first-line antiretroviral therapy in South Africa (Open Forum Infectious Diseases, 2023)

(untitled) - Asare, K; Lewis, L; van der Molen, J; Sookrajh, Y; Khubone, T; Moodley, P; Lessells, RJ; Naidoo, K; Sosibo, P; Garrett, N; Dorward, J